Video

HPV epidemic continues to fuel incidence of head and neck cancer


 

Community Oncology Editor Dr. Debra Patt spoke with Dr. Ezra Cohen at the Oncology Practice Summit in Las Vegas about the HPV epidemic and its effect on the pathophysiology and treatment of head and neck cancers.

The Oncology Practice Summit was the 8th annual meeting of Community Oncology, the journal of clinical issues in community practice. Dr. Patt was a co-chair of the Summit, which was hosted this year by Community Oncology as well as The Journal of Supportive Oncology and The Oncology Report.

Recommended Reading

FDA Approves REMS for Long-Acting Opioids
MDedge Hematology and Oncology
Washington Post Blasts Proliferation of ESAs for Anemia
MDedge Hematology and Oncology
Radiation Oncologists Say Medicare Cuts Could Shutter Practices
MDedge Hematology and Oncology
DNA Alone Inadequate to Identify HPV-Related Cancers
MDedge Hematology and Oncology
CCR7 Predicts Cervical Metastasis in Oral Cancer
MDedge Hematology and Oncology
Robotic Surgery Beneficial in HPV-, Non-HPV-Related Oral Cancer
MDedge Hematology and Oncology
Doxepin Rinse Eases Mucositis Pain in Cancer Patients
MDedge Hematology and Oncology
FDA Approves Second Drug for Rare Thyroid Cancer
MDedge Hematology and Oncology
Adding cetuximab to chemoradiotherapy harmful in esophageal cancer
MDedge Hematology and Oncology
Escitalopram during cancer treatment reduces depression risk
MDedge Hematology and Oncology

Related Articles